Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patricia Ernst

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Cell Cycle (Georgetown, Tex.)|June 5, 2019
Hematopoietic transformation in the absence of MLL1/KMT2A: distinctions in target gene reactivationYufei Chen, Patricia Ernst
International Journal of Hematology|November 1, 2016
SET/MLL family proteins in hematopoiesis and leukemiaWeiwei Yang, Patricia Ernst
Current Opinion in Hematology|April 5, 2017
Distinct functions of histone H3, lysine 4 methyltransferases in normal and malignant hematopoiesisWeiwei Yang, Patricia Ernst
Cancer Cell|July 15, 2016
Context, Context, Context: New Gene Programs Linked to Bad Behavior in MLL-AF9-Initiated LeukemiaTatsuro Watanabe, Patricia Ernst
Experimental Hematology|September 30, 2014
Two decades of leukemia oncoprotein epistasis: the MLL1 paradigm for epigenetic deregulation in leukemiaBin E Li, Patricia Ernst
Briefings in Functional Genomics|June 2, 2012
WRAD: enabler of the SET1-family of H3K4 methyltransferasesPatricia Ernst, Christopher R Vakoc
Cell Cycle (Georgetown, Tex.)|August 27, 2013
Cell context in the control of self-renewal and proliferation regulated by MLL1Erika L Artinger, Patricia Ernst
Experimental Hematology|September 8, 2025
KMT2A-rearranged leukemia: from mechanism to drug developmentPatricia Ernst, Perpetual S Kyei, Akihiko Yokoyama
Current Opinion in Hematology|June 4, 2002
The role of MLL in hematopoiesis and leukemiaPatricia Ernst, Jing Wang, Stanley J Korsmeyer
Scandinavian Journal of Public Health|March 21, 2023
The burden of disease due to COVID-19 in Sweden 2020-2021: A disability-adjusted life years (DALYs) studyJad Shedrawy, Patricia Ernst, Knut Lönnroth, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Cell Cycle (Georgetown, Tex.)|June 5, 2019
Hematopoietic transformation in the absence of MLL1/KMT2A: distinctions in target gene reactivationYufei Chen, Patricia Ernst
International Journal of Hematology|November 1, 2016
SET/MLL family proteins in hematopoiesis and leukemiaWeiwei Yang, Patricia Ernst
Current Opinion in Hematology|April 5, 2017
Distinct functions of histone H3, lysine 4 methyltransferases in normal and malignant hematopoiesisWeiwei Yang, Patricia Ernst
Cancer Cell|July 15, 2016
Context, Context, Context: New Gene Programs Linked to Bad Behavior in MLL-AF9-Initiated LeukemiaTatsuro Watanabe, Patricia Ernst
Experimental Hematology|September 30, 2014
Two decades of leukemia oncoprotein epistasis: the MLL1 paradigm for epigenetic deregulation in leukemiaBin E Li, Patricia Ernst
Briefings in Functional Genomics|June 2, 2012
WRAD: enabler of the SET1-family of H3K4 methyltransferasesPatricia Ernst, Christopher R Vakoc
Cell Cycle (Georgetown, Tex.)|August 27, 2013
Cell context in the control of self-renewal and proliferation regulated by MLL1Erika L Artinger, Patricia Ernst
Experimental Hematology|September 8, 2025
KMT2A-rearranged leukemia: from mechanism to drug developmentPatricia Ernst, Perpetual S Kyei, Akihiko Yokoyama
Current Opinion in Hematology|June 4, 2002
The role of MLL in hematopoiesis and leukemiaPatricia Ernst, Jing Wang, Stanley J Korsmeyer
Scandinavian Journal of Public Health|March 21, 2023
The burden of disease due to COVID-19 in Sweden 2020-2021: A disability-adjusted life years (DALYs) studyJad Shedrawy, Patricia Ernst, Knut Lönnroth, et al.
Pageof 5